Fluorinov Pharma Overview

  • Founded

  • 2008

Founded
  • Status

  • Acquired/​Merged

  • Latest Deal Type

  • M&A

  • Latest Deal Amount

  • $31.7M

Fluorinov Pharma General Information

Description

Operator of a pharmaceutical company intended to develop fluorine-based novel, safer and more effective medicine. The company's services include developing small molecule product portfolio for Multiple Myeloma, Waldenström's Macroglobulinemia, Leukemia, Glioblastoma, Lung and Pancreatic Cancers and Central Nervous System disorders, enabling patients to avail therapeutics to treat and avoid cancer diseases.

Contact Information

Website
www.fluorinovpharma.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Other Pharmaceuticals and Biotechnology
Pharmaceuticals
Acquirer
Trillium Therapeutics
Primary Office
  • 101 College Street, MaRS Centre, South Tower
  • Suite 300, L-349
  • Toronto, Ontario M5G 1L7
  • Canada

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Fluorinov Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 27-Jan-2016 $31.7M 00.000 000.00 Completed Generating Revenue
3. Early Stage VC 07-Jan-2015 00.000 Completed Generating Revenue
2. Early Stage VC 07-Jun-2012 $1.47M $1.47M Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2010 Completed Generating Revenue
To view Fluorinov Pharma’s complete valuation and funding history, request access »

Fluorinov Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a pharmaceutical company intended to develop fluorine-based novel, safer and more effective medicine. The co
Drug Discovery
Toronto, Canada
00.000
00.00 0000-00-00
000000&0 00.000

000000

m, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo conse
0000 000000000
Stockholm, Sweden
00 As of 0000
000.00
00.00 0000-00-00
0000000000 0 000.00

0000 0

d do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad mini
000000000000000
Stamford, CT
00 As of 0000
00000
0.000 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Fluorinov Pharma Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Gesynta Pharma Venture Capital-Backed Stockholm, Sweden 00 000.00 0000000000 0 000.00
0000 00000000 Formerly VC-backed Stamford, CT 00 00000 000000&0 00000
000000 Corporation Paris, France 00000 000000000000
000000000 000000 Venture Capital-Backed Burlington, MA 00 00000 0000000000 0 00000
0000000 000000 Venture Capital-Backed Barcelona, Spain 00 000.00 000000000000 000.00
You’re viewing 5 of 9 competitors. Get the full list »

Fluorinov Pharma Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
FACIT Venture Capital Minority 000 0000 000000 0
Ontario Institute for Cancer Research Not-For-Profit Venture Capital Minority 000 0000 000000 0
To view Fluorinov Pharma’s complete investors history, request access »

Ready to get started?

Request a free trial